| Literature DB >> 27884102 |
Mariana P Berton1, Larissa F S Fonseca1, Daniela F J Gimenez1, Bruno L Utembergue2, Aline S M Cesar3, Luiz L Coutinho3,4, Marcos Vinicius A de Lemos1, Carolyn Aboujaoude1, Angélica S C Pereira2, Rafael M de O Silva1, Nedenia B Stafuzza1, Fabieli L B Feitosa1, Hermenegildo L J Chiaia1, Bianca F Olivieri1, Elisa Peripolli1, Rafael L Tonussi1, Daniel M Gordo1, Rafael Espigolan1, Adrielle M Ferrinho2, Lenise F Mueller5, Lucia G de Albuquerque1,4, Henrique N de Oliveira1,4, Susan Duckett6, Fernando Baldi7,8.
Abstract
BACKGROUND: Fatty acid type in beef can be detrimental to human health and has received considerable attention in recent years. The aim of this study was to identify differentially expressed genes in longissimus thoracis muscle of 48 Nellore young bulls with extreme phenotypes for fatty acid composition of intramuscular fat by RNA-seq technique.Entities:
Keywords: Bos indicus; Human health; Lipid composition; RNA-seq; Transcriptome
Mesh:
Substances:
Year: 2016 PMID: 27884102 PMCID: PMC5123393 DOI: 10.1186/s12864-016-3232-y
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Descriptive statistics and analysis of variance for the fatty acidsa for groups of animals with extreme phenotypes (LOW and HIGH)
| Fatty acid | Terminology | LOW groupb | HIGH groupc |
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Min | Max | Mean | SD | Min | Max | Mean | SD | |||
| C14:0 | Myristic acid | 0.95 | 1.68 | 1.38 | 0.22 | 2.49 | 3.73 | 2.88 | 0.35 | < 0.01 |
| C16:0 | Palmitic acid | 16.54 | 20.35 | 18.84 | 0.42 | 23.24 | 28.57 | 24.48 | 0.42 | |
| C18:0 | Stearic acid | 10.86 | 12.80 | 11.80 | 0.22 | 15.88 | 17.78 | 16.68 | 0.22 | |
| C18:1 cis-9 | Oleic acid | 25.57 | 29.51 | 27.60 | 0.38 | 34.51 | 37.51 | 35.85 | 0.38 | |
| C18:2 cis-9 trans-11 | CLA | 0.14 | 0.20 | 0.18 | 0.02 | 0.33 | 0.59 | 0.41 | 0.02 | |
| C18:2 cis-9 cis −12 | Linoleic acid | 2.47 | 4.92 | 4.13 | 0.28 | 8.96 | 11.82 | 9.98 | 0.27 | |
| C18:3 n3 | α-Linolenic acid | 0.23 | 0.49 | 0.41 | 0.03 | 0.87 | 1.20 | 1.00 | 0.03 | |
| SFA | Sum of SFA | 39.91 | 42.05 | 41.10 | 0.32 | 45.37 | 49.62 | 46.87 | 0.32 | < 0.01 |
| MUFA | Sum of MUFA | 30.14 | 34.50 | 32.75 | 0.39 | 40.44 | 43.71 | 42.20 | 0.39 | |
| PUFA | Sum of PUFA | 4.33 | 8.24 | 7.16 | 0.46 | 15.79 | 20.46 | 17.21 | 0.46 | |
| PUFA/SFA | PUFA and SFA ratio | 0.09 | 0.18 | 0.16 | 0.01 | 0.36 | 0.51 | 0.40 | 0.01 | |
| n3 | Sum of n-3 | 2.78 | 5.39 | 4.49 | 0.29 | 9.77 | 12.94 | 10.89 | 0.29 | < 0.01 |
| n6 | Sum of n-6 | 1.24 | 2.65 | 2.18 | 0.20 | 5.14 | 7.62 | 6.14 | 0.20 | |
| n6/n3 | n6 and n3 ratio | 1.45 | 1.64 | 1.57 | 0.03 | 2.15 | 2.63 | 2.27 | 0.03 | |
aThe concentration of fatty acids are expressed as a percentage of total fatty acid methyl esters (FAME); bLOW group: ten lowest extreme phenotypes; cHIGH group: ten highest extreme phenotypes
Average number of pair-end reads, number of mapped reads and concordant pair alignment rate (%) for HIGH and LOWa groups for each beef fatty acid
| Fatty acid | HIGH groupa | LOW groupb | ||||
|---|---|---|---|---|---|---|
| Input reads | Mapped reads | Concordant pair alignment rate (%) | Input reads | Mapped reads | Concordant pair alignment rate (%) | |
| SFA | 20071041 | 14437527 | 72.4 | 19638545 | 14820629 | 74.5 |
| MUFA | 20240465 | 14684305 | 72.8 | 16939278 | 12297985 | 72.4 |
| PUFA | 17185305 | 12864023 | 73.6 | 20237062 | 14549977 | 72.4 |
| PUFA/SFA | 16414850 | 12317003 | 73.7 | 20237100 | 14568890 | 72.5 |
| n3 | 17139100 | 12827764 | 73.6 | 20222528 | 14551467 | 72.4 |
| n6 | 17185305 | 12864023 | 73.6 | 20847167 | 15061920 | 72.7 |
| n6/n3 | 16210236 | 11638824 | 72.4 | 16917230 | 12764008 | 74.1 |
| C14:0 | 18018166 | 12949199 | 72.4 | 17468012 | 13076106 | 73.6 |
| C16:0 | 19244978 | 13835678 | 72.3 | 17828062 | 13334095 | 73.6 |
| C18:0 | 18384047 | 13412632 | 73.1 | 17381770 | 13032452 | 73.9 |
| C18:1 cis-9 | 19653791 | 14182228 | 72.4 | 15553754 | 11278425 | 72.4 |
| C18:2 cis-9 trans-11 | 20179794 | 15010030 | 74.1 | 18123403 | 13240952 | 73.1 |
| C18:2 cis-9 cis −12 | 17185305 | 12864023 | 73.6 | 20847167 | 15061920 | 72.7 |
| C18:3 n3 | 18224781 | 13583864 | 73.4 | 19220721 | 13826217 | 72.4 |
aHIGH group: Ten highest extreme phenotypes; bLOW group: Ten lowest extreme phenotypes
Description of differentially expressed genes identified between groups of Nellore bulls with different fatty acid composition in longissimus thoracis muscle
| Ensembl_gene_ID | Gene symbol | BTA: locus | Function | FA | Fold change |
|
|---|---|---|---|---|---|---|
| ENSBTAG00000033803 |
| 9:28834077–28837863 | Cytosolic fatty-acid and lipid binding | C18:3 n3 | 27.891 | 0.010 |
| ENSBTAG00000022570 |
| 13:43947620–44116989 | Fatty acid metabolic process | MUFA | −2.100 | 0.007 |
| ENSBTAG00000004860 |
| 7:26237928–26329594 | Fatty acid transporter | MUFA | 0.855 | 0.004 |
| ENSBTAG00000012885 |
| 15:17999931–18028984 | Fatty acid metabolism, Synthesis and degradation of ketone bodies | n6 | 0.444 | 0.047 |
| ENSBTAG00000005105 |
| 2:127684836–127720396 | Lipid catabolic process | C18:0 | −0.750 | 0.050 |
| ENSBTAG00000022449 |
| 6:99233278–99410753 | Fatty acid metabolic process; fatty acid, unsaturated fatty acid and lipid biosynthetic process | C18:0 | 0.821 | 0.030 |
| ENSBTAG00000001444 |
| 23:27083668–27136954 | Fatty acid metabolism | C18:1cis-9 | −0.640 | 0.004 |
| ENSBTAG00000006716 |
| 11:93219286–93245045 | Fatty acid metabolic process; fatty acid and unsaturated fatty acid biosynthetic process | C18:1cis-9 | −0.824 | 0.010 |
| ENSBTAG00000007763 |
| 11:63290421–63395507 | Carboxylic acid transport | C18:0 | −1.502 | 0.006 |
| ENSBTAG00000015228 |
| 7:63748884–63756646 | Organic acid and lipid biosynthetic process | C18:0 | 0.605 | 0.033 |
| ENSBTAG00000016819 |
| 2:122723224–122783830 | Cytosolic fatty-acid and lipid binding | PUFA/SFA | 0.895 | 0.011 |
| ENSBTAG00000011917 |
| 26:32963413–33003349 | Fatty acid metabolic process | PUFA/SFA | −0.664 | 0.011 |
| ENSBTAG00000018248 |
| 22:60443563–60493810 | Lipid metabolism | PUFA/SFA | −0.620 | 0.011 |
| ENSBTAG00000038321 |
| 18:51216018–51227395 | Lipid catabolic process, and Insulin signaling pathway | PUFA/SFA | −0.620 | 0.011 |
| ENSBTAG00000004178 |
| 22:43379503–43410315 | Metabolic and catabolic process, beta-oxidation of fatty acid, lipid catabolic process and organic acid catabolic process | n6 | −0.486 | 0.025 |
| ENSBTAG00000008063 |
| 5:117151548–117233112 | Fatty acid metabolic process | n6 | −0.534 | 0.003 |
| ENSBTAG00000017542 |
| 23:9340954–9353750 | metabolic and catabolic process, beta-oxitation, transport and oxidation of fatty acids | n6 | −0.643 | 0.011 |
| ENSBTAG00000033089 |
| 13:32347675–32369621 | Biosynthesis of unsaturated fatty acids | ω6 | 0.500 | 0.016 |
| ENSBTAG00000007331 |
| 1:123322466–123444003 | Carboxylic acid binding | C18:2cis-9cis-12 | 0.886 | 0.013 |
| ENSBTAG00000001417 |
| 25:18349701–18413889 | Metabolic and biosynthetic process of fatty acid; biosynthetic process of lipid, organic acid and carboxylic acid. | n3 | −176.413 | 0.013 |
| ENSBTAG00000019813 |
| 1:81005167–81018328 | Metabolic and catabolic process, beta-oxidation and oxidation and regulation of metabolic of fatty acid | n3 | −118.366 | 0.013 |
| ENSBTAG00000037526 |
| 14:46833664–46838053 | Cytosolic fatty-acid binding | n3 | −135.344 | 0.013 |
| ENSBTAG00000001154 |
| 15:55940756–55973229 | Lipid biosynthetic process | C18:2cis-9cis-12 | −0.626 | 0.025 |
| ENSBTAG00000021287 |
| 5:53987908–54214799 | Monocarboxylic acid transmembrane transporter activity | C14:0 | 0.816 | 0.040 |
| ENSBTAG00000005259 |
| 15:54213565–54224051 | Fatty acid metabolic process | C18:1cis-9 | 0.615 | 0.023 |
| ENSBTAG00000016864 |
| 13:67874473–67910095 | Lipid transport | C14:0 | 1.950 | 0.040 |
| ENSBTAG00000012855 |
| 8:67481088–67511227 | Metabolic and biosynthetic process of fatty acid | C16:0 | 0.870 | 0.02 |
| ENSBTAG00000015978 |
| 8:49624472–49642916 | Transport of lipid, monocarboxylic acid, organic acid, fatty acid, long-chain fatty acid and carboxylic acid; arachidonic acid secretion | C18:0 | 0.826 | 0.006 |
| ENSBTAG00000006447 |
| 25:18605634–18656582 | Lipid metabolism | C18:2cis-9cis-12 | −1.853 | 0.012 |
| ENSBTAG00000004281 |
| 13:42963403–43076853 | Acetyl-CoA metabolic process | C14:0 | 1.184 | 0.040 |
| ENSBTAG00000016514 |
| 17:546397–697915 | Insulin processing | C14:0 | 1.490 | 0.040 |
| ENSBTAG00000000448 |
| 1:72572940–72608810 | Synthesis and degradation of ketone bodies | C14:0 | 1.045 | 0.040 |
Fig. 1Metabolic pathways of ACSM3 gene (6.2.1.2) [70]
Fig. 2Metabolic Pathways of ACSS1 gene (6.2.1.1) [71]
Gene Ontology (GO) terms enriched with differentially expressed genes (FDR < 0.1)
| GO terms | Numbera |
| FDR |
|---|---|---|---|
|
| |||
| GO:0005576 - extracellular region | 106 | 5,93E-15 | 7.93E-12 |
| GO:0044421 - extracellular region part | 65 | 8,15E-14 | 1,10E-10 |
| GO:0031012 - extracellular matrix | 39 | 2,68E-13 | 3,61E-10 |
| GO:0005578 -proteinaceous extracellular matrix | 34 | 4,96E-11 | 6,68E-08 |
|
| |||
| GO:0005539 - glycosaminoglycan binding | 22 | 1,31E-13 | 1,93E-10 |
| GO:0001871- pattern binding | 22 | 1,03E-11 | 1,51E-08 |
| GO:0030247- polysaccharide binding | 22 | 1,03E-11 | 1,51E-08 |
| GO:0030246 - carbohydrate binding | 29 | 1,37E-09 | 2,01E-06 |
| GO:0008201- heparin binding | 13 | 1,64E-07 | 2,41E-04 |
| GO:0030528 - transcription regulator activity | 64 | 1,19E-05 | 0,017513 |
| GO:0003700 - transcription factor activity | 44 | 6,64E-05 | 0,097714 |
|
| |||
| GO:0001501 - skeletal system development | 24 | 6,72E-08 | 1,16E-04 |
| GO:0030198 - extracellular matrix organization | 16 | 1,81E-07 | 3,11E-04 |
| GO:0043062 - extracellular structure organization | 17 | 1,06E-06 | 0,001821 |
| GO:0009611 - response to wounding | 26 | 5,79E-06 | 0,009976 |
| GO:0006954 - inflammatory response | 18 | 3,19E-05 | 0,05502 |
| GO:0007517 - muscle organ development | 16 | 4,26E-05 | 0,073391 |
| GO:0043009 - chordate embryonic development | 23 | 4,66E-05 | 0,080367 |
| GO:0060537 - muscle tissue development | 14 | 5,11E-05 | 0,088045 |
| GO:0009792 - embryonic development ending in birth or egg hatching | 23 | 5,13E-05 | 0,088388 |
anumber of differentially expressed genes
Fig. 3Metabolic pathway of DGAT2 (2.3.1.20) and LPL (3.1.1.34) genes [72]
Fig. 4Metabolic pathway for BDH1 (1.1.1.30) and ACAT1 (2.3.1.9) genes [73]